Ibuprofen does not impair renal function in patients undergoing infrarenal aortic surgery with epidural anaesthesia. 1998

A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
University Clinics Ulm, Department of Anaesthesiology, Germany.

OBJECTIVE To investigate the effect of preoperative ibuprofen administration on renal function during and after infrarenal aortic surgery under thoracolumbar epidural anaesthesia (EPA). METHODS A prospective randomised, double-blinded clinical study. METHODS Operation room and intensive care unit in a university hospital. METHODS Twenty-six consecutive patients scheduled for elective infrarenal aortic surgery. METHODS The patients were prospectively randomised to receive 400 mg ibuprofen intravenously (i.v.) or a placebo aliquot before surgery. RESULTS We assessed renal function by calculating creatinine clearance, and fractional sodium excretion before surgery (baseline), 1 h after cross-clamping (intraoperative), 6 h after cross-clamping (postoperative) and 24 h after cross-clamping (on the 1 st postoperative day). At each point in time, we additionally registered haemodynamics and determined the plasma concentration of 6-keto-PGF1alpha (stable metabolite of prostacyclin, PGI2), bicyclic PGE2 (stable metabolite of PGE1 E2), active renin, aldosterone and vasopressin by radioimmunoassays. Throughout the observation period the renal function parameters mostly remained within the normal range without a significant difference between ibuprofen- and placebo-treated patients (creatinine clearance: baseline 41 +/- 3 vs 38 +/- 6, intraoperative 57 +/- 8 vs 64 +/- 11, postoperative 64 +/- 9 vs 56 +/- 9, first postoperative day 43 +/- 5 vs 47 +/- 6 ml x min x m(-2), means +/- SEM). The plasma levels of 6-keto-PGF1alpha (68 +/- 8 vs 380 +/- 71* ng x l(-1)), bicyclic PGE2 (57 +/- 5 vs 88 +/- 9* ng x l(-1)) and vasopressin (14 +/- 7 vs 45 +/- 10* ng x l(-1), p < 0.0125), however, were significantly higher during the intraoperative period in the placebo-treated patients. CONCLUSIONS The inhibition of endogenous prostaglandin release by ibuprofen does not substantially impair renal function during infrarenal aortic surgery under EPA.

UI MeSH Term Description Entries
D007052 Ibuprofen A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties Advil,Benzeneacetic Acid, alpha-methyl-4-(2-methylpropyl)- trimethylsilyl ester,Brufen,Ibumetin,Ibuprofen, (+-)-Isomer,Ibuprofen, (R)-Isomer,Ibuprofen, (S)-Isomer,Ibuprofen, Aluminum Salt,Ibuprofen, Calcium Salt,Ibuprofen, Copper (2+) Salt,Ibuprofen, Magnesium Salt,Ibuprofen, Potassium Salt,Ibuprofen, Sodium Salt,Ibuprofen, Zinc Salt,Ibuprofen-Zinc,Motrin,Nuprin,Rufen,Salprofen,Trauma-Dolgit Gel,alpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid,Ibuprofen Zinc,Trauma Dolgit Gel
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
January 1996, Nephron,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
February 1993, Anesthesia and analgesia,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
January 2023, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
April 1992, Anesthesia and analgesia,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
January 1983, Journal of clinical pharmacology,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
January 2000, British journal of anaesthesia,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
January 2007, Medical hypotheses,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
February 1990, Journal of vascular surgery,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
October 2003, Journal of vascular surgery,
A Brinkmann, and W Seeling, and C F Wolf, and E Kneitinger, and N Vogt, and G Steinbach, and K H Orend, and P Radermacher, and M Georgieff
October 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
Copied contents to your clipboard!